Skip to main content
. 2018 Feb 1;9(1):17–30. doi: 10.14336/AD.2017.0230

Figure 2. The lifespan-shortening effects of high glucose reduced by Olaparib treatment.

Figure 2.

(A) Determination of lifespan for N2 worms exposed to 16 mM glucose together with 100 uM or 0 µM Olaparib (P<0.0001, log-rank test, n=100); (B) Determination of lifespan for N2 worms exposed to 25 mM glucose together with 100 uM or 0 µM Olaparib (P<0.05, log-rank test, n=100).